Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-02-05EMA Authorised: Enyglid (repaglinide) — Krka, d.d., Novo mesto
Enyglid (repaglinide) by Krka has been authorized in the EU for the treatment of type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India [Phase 4]
Phase 4 clinical trial evaluating dulaglutide (LY2189265) in participants with Type 2 diabetes mellitus in India has completed, with results…
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Preclinical Research of mμSORS for Noninvasive Blood Glucose Detection [NA]
This document reports a completed preclinical study evaluating the mμSORS technology for noninvasive blood glucose detection in the context …
-
EMA approval · 2025-02-04EMA Authorised: Repaglinide Krka (repaglinide) — Krka, d.d., Novo mesto
The EMA authorised Repaglinide Krka for Type 2 diabetes mellitus. The product is a generic repaglinide from Krka, d.d., Novo mesto.
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: Low-carbohydrate Versus Low-fat Breakfast in Type 2 Diabetes [NA]
A completed trial from the University of British Columbia compared a low-carbohydrate breakfast to a low-fat breakfast in adults with Type 2…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD) [Phase 4]
A Phase 4 clinical trial evaluating the SGLT2 inhibitor dapagliflozin in adults with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver D…
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: Vildagliptin Versus Glimepiride in Type 2 Diabetic Patients [NA]
This document reports the completion of a clinical trial comparing vildagliptin to glimepiride in adults with Type 2 diabetes mellitus.
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: EffectiVenEss of a Rehabilitation Treatment With Nordic Walking in obEse or oveRweight Patients [NA]
A clinical trial is investigating the effects of Nordic walking rehabilitation in obese or overweight patients with cardiovascular disease a…
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: Inflammatory Response and Gingival iNOS Levels in Diabetic vs. Non-Diabetic Periodontitis Patients
A completed clinical trial comparing inflammatory responses and gingival iNOS levels in periodontitis patients with Type 2 diabetes versus n…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: An Observational Study to Evaluate Tolerability of Canagliflozin and Sulphonylurea in Type 2 Diabetes Patients During Ramadan
This completed observational study evaluated tolerability of combining canagliflozin with a sulphonylurea in adults with type 2 diabetes dur…
-
CLINICAL_TRIALS research · 2025-02-03Clinical Trial Update: Isoleucine Intake and Intermediary Metabolism in Type 2 Diabetes [NA]
The clinical trial investigating isoleucine intake and intermediary metabolism in Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS research · 2025-02-03Clinical Trial Update: Inflammation's Impact on Heart Disease and Diabetes
A University of Aarhus-led clinical trial is currently recruiting to study how inflammation influences cardiovascular disease and type 2 dia…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Hybrid Method Between Low-ratio Premixed Insulin and Short Acting Insulin in Fasting Type 2 Diabetic Patients in Ramadan
A completed clinical trial from Sohag University evaluating a hybrid method combining low-ratio premixed insulin with short-acting insulin i…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Targeting Hyaluronan Accumulation Through Exercise in T2DM [NA]
A clinical trial sponsored by NYU Langone Health investigating whether exercise can reduce hyaluronan accumulation in Type 2 Diabetes Mellit…
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: Mobile App Logging for Diabetes in Pregnancy [NA]
This clinical trial update concerns a mobile app logging study for diabetes during pregnancy. Recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: The Effectiveness of Multimedia Education on Hypoglycemic Management. [NA]
The trial evaluated the effectiveness of multimedia education for managing hypoglycemia in people with type 2 diabetes. Results have been po…
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People With T2 Diabetes [NA]
Clinical trial update evaluating the use of flash continuous glucose monitoring to reduce hyperglycemia in people with Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: T2 FSL2 Weight Loss
Abbott Diabetes Care's T2 FSL2 Weight Loss trial in Type 2 diabetes mellitus has been terminated.
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Preventing Medication Mismanagement in People Living with Dementia Through Automated Medication Dispensing with Facial Recognition and Video Observation [Phase 2]
Phase 2 trial evaluating automated medication dispensing with facial recognition and video observation to prevent medication mismanagement i…
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Postoperative Basal Bolus or Sliding Scale Insulin Regimen in DM2 and Its Effect on Surgical Site Infections. [NA]
A recruiting clinical trial comparing basal-bolus versus sliding-scale insulin regimens after surgery in type 2 diabetes and evaluating impa…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes [Phase 2]
A Phase 2 trial of an interleukin-1 receptor antagonist evaluating cephalic-phase insulin secretion in healthy individuals and people with T…
-
FDA approval · 2025-01-28FDA Approved: OZEMPIC — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for Ozempic (semaglutide) from Novo Nordisk, updating the product label following the submission…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Comparative Outcomes of One-Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass As Revisional Procedures Following Failed Restrictive Bariatric Surgery
A completed clinical trial comparing one-anastomosis gastric bypass (OAGB) versus Roux-en-Y gastric bypass (RYGB) as revisional procedures a…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Hydroxyl Free Radical Associated Effects of SGLT-2 Inhibitors in Type 2 Diabetes
A completed clinical trial evaluating hydroxyl free radical-related effects of SGLT-2 inhibitors in Type 2 diabetes mellitus.
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Music Effect on the Self-Injection, Testing Fear and Pain [NA]
A clinical trial update indicates a study on the effect of music therapy on fear and pain during insulin self-injection in type 2 diabetes m…